DCF — DEACONESS MEDICAL CENTER
Enterprise Value: $-405.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-405.8M
Enterprise Value
$-135.5M
PV of Cash Flows
$-270.3M
PV of Terminal Value
$-435.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $464.9M | $-21.4M | -5.0% | $-41.1M | $-37.3M |
| Year 2 | $478.8M | $-17.3M | -4.0% | $-37.5M | $-31.0M |
| Year 3 | $493.2M | $-12.8M | -3.0% | $-33.7M | $-25.3M |
| Year 4 | $508.0M | $-10.7M | -2.0% | $-32.2M | $-22.0M |
| Year 5 | $523.2M | $-9.7M | -2.0% | $-31.9M | $-19.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-405.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$451.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05104796443085308
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5